OUTCOMES OF AUTOLOGOUS TRANSPLANT, ALLOGENEIC TRANSPLANT, AND CAR T CELL THERAPY IN TP53 ALTERED MANTLE CELL LYMPHOMA: A MULTI‐INSTITUTION RETROSPECTIVE ANALYSIS
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 156-158
10.1002/hon.3163_103